OTC Markets OTCQB - Delayed Quote USD

Biotricity, Inc. (BTCY)

Compare
0.4600 -0.0250 (-5.15%)
As of 12:17 PM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
12,244.3230
12,063.3450
9,639.0570
7,650.2690
3,384.7670
--
Cost of Revenue
3,441.5780
3,707.0640
4,197.0240
3,080.1160
2,112.0350
--
Gross Profit
8,802.7450
8,356.2810
5,442.0330
4,570.1530
1,272.7320
--
Operating Expense
16,431.3740
17,184.5500
20,851.7440
21,306.9560
14,624.5260
--
Operating Income
-7,628.6290
-8,828.2690
-15,409.7110
-16,736.8030
-13,351.7940
--
Net Non Operating Interest Income Expense
-5,887.3930
-5,191.7230
-2,582.6180
-10,569.5930
-2,481.1550
--
Other Income Expense
-859.8990
-74.2910
-665.8140
-1,824.0810
341.7730
--
Pretax Income
-14,375.9210
-14,094.2830
-18,658.1430
-29,130.4770
-15,491.1760
--
Net Income Common Stockholders
-18,275.6730
-14,928.9600
-19,533.6830
-30,219.4540
-16,453.3240
--
Diluted NI Available to Com Stockholders
-18,275.6730
-14,928.9600
-19,533.6830
-30,219.4540
-16,453.3240
--
Basic EPS
-1.74
-1.66
-2.26
-3.99
-2.63
--
Diluted EPS
-1.74
-1.66
-2.26
-3.99
-2.63
--
Basic Average Shares
10,345.9990
8,991.7660
8,659.7180
7,574.9530
6,253.8290
--
Diluted Average Shares
10,345.9990
8,991.7660
8,659.7180
7,574.9530
6,253.8290
--
Total Operating Income as Reported
-7,628.6290
-8,828.2690
-15,409.7110
--
--
--
Total Expenses
19,872.9520
20,891.6140
25,048.7680
24,387.0720
16,736.5610
--
Net Income from Continuing & Discontinued Operation
-14,375.9210
-14,094.2830
-18,658.1430
-29,130.4770
-15,491.1760
--
Normalized Income
-13,977.3840
-14,104.0600
-18,174.2700
-28,446.9180
-15,900.0480
--
Interest Expense
5,887.3930
5,191.7230
2,582.6180
10,569.5930
2,481.1550
--
Net Interest Income
-5,887.3930
-5,191.7230
-2,582.6180
-10,569.5930
-2,481.1550
--
EBIT
-8,488.5280
-8,902.5600
-16,075.5250
-18,560.8840
-13,010.0210
--
EBITDA
-8,482.5760
-8,896.6070
-16,069.5720
-18,558.5760
-13,010.0210
--
Reconciled Cost of Revenue
3,441.5780
3,707.0640
4,197.0240
3,080.1160
2,112.0350
--
Reconciled Depreciation
5.9520
5.9530
5.9530
2.3080
--
--
Net Income from Continuing Operation Net Minority Interest
-14,375.9210
-14,094.2830
-18,658.1430
-29,130.4770
-15,491.1760
--
Total Unusual Items Excluding Goodwill
-398.5370
9.7770
-483.8730
-683.5590
408.8720
--
Total Unusual Items
-398.5370
9.7770
-483.8730
-683.5590
408.8720
--
Normalized EBITDA
-8,084.0390
-8,906.3840
-15,585.6990
-17,875.0170
-13,418.8930
--
3/31/2020 - 2/19/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers